Page last updated: 2024-08-16

probenecid and vx 702

probenecid has been researched along with vx 702 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chakilam, AR; Jayaraj, A; Taft, DR; Tamhane, M; Thakkar, V	1

Other Studies

1 other study(ies) available for probenecid and vx 702

Article	Year
Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model. Drug development and industrial pharmacy, 2010, Volume: 36, Issue:3 Topics: Algorithms; Animals; Antirheumatic Agents; Cimetidine; Drug Interactions; Enzyme Inhibitors; Glomerular Filtration Rate; Immunologic Factors; Kidney; Kinetics; Male; Methotrexate; Organic Anion Transporters; Organic Cation Transport Proteins; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Perfusion; Phenylurea Compounds; Probenecid; Rats; Rats, Sprague-Dawley; Ultrafiltration	2010

Article

Year

Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.

Drug development and industrial pharmacy, 2010, Volume: 36, Issue:3

Topics: Algorithms; Animals; Antirheumatic Agents; Cimetidine; Drug Interactions; Enzyme Inhibitors; Glomerular Filtration Rate; Immunologic Factors; Kidney; Kinetics; Male; Methotrexate; Organic Anion Transporters; Organic Cation Transport Proteins; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Perfusion; Phenylurea Compounds; Probenecid; Rats; Rats, Sprague-Dawley; Ultrafiltration

2010